Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins

PURPOSE: Although preclinical, epidemiological and prior clinical trial data suggest that green tea catechins (GTCs) may reduce prostate cancer (PCa) risk, several preclinical studies and case reports have reported liver toxicities and acute gastrointestinal bleeding. Based on these observations, re...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Kumar, Nagi B., Pow-Sang, Julio, Spiess, Philippe E., Park, Jong, Salup, Raoul, Williams, Christopher R., Parnes, Howard, Schell, Michael J.
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5340117/
https://ncbi.nlm.nih.gov/pubmed/28053292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12222
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki